Christopher J. Strock

1.0k total citations
24 papers, 848 citations indexed

About

Christopher J. Strock is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christopher J. Strock has authored 24 papers receiving a total of 848 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christopher J. Strock's work include Cancer-related Molecular Pathways (7 papers), Prostate Cancer Treatment and Research (4 papers) and Fungal Plant Pathogen Control (3 papers). Christopher J. Strock is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Prostate Cancer Treatment and Research (4 papers) and Fungal Plant Pathogen Control (3 papers). Christopher J. Strock collaborates with scholars based in United States and Germany. Christopher J. Strock's co-authors include Barry D. Nelkin, Douglas W. Ball, Jong‐In Park, Jenifer A. Bradley, Bruce L. Finkelstein, Monica Metea, G. Steven Bova, John T. Isaacs, Eric K. Nakakura and Paul A. Johnston and has published in prestigious journals such as Molecular and Cellular Biology, The Journal of Clinical Endocrinology & Metabolism and Cancer Research.

In The Last Decade

Christopher J. Strock

24 papers receiving 834 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher J. Strock United States 15 413 336 116 106 100 24 848
Yoshiki Fukasawa Japan 10 900 2.2× 285 0.8× 199 1.7× 133 1.3× 43 0.4× 13 1.6k
Antonio Chiloeches Spain 19 1.1k 2.7× 412 1.2× 77 0.7× 116 1.1× 94 0.9× 31 1.5k
Haining Zhen China 22 685 1.7× 241 0.7× 88 0.8× 48 0.5× 82 0.8× 52 1.4k
Hadas Reuveni Israel 15 599 1.5× 129 0.4× 72 0.6× 65 0.6× 69 0.7× 27 817
Judit Dobos Hungary 18 443 1.1× 377 1.1× 81 0.7× 31 0.3× 97 1.0× 33 989
Terence F. McGuire United States 17 678 1.6× 265 0.8× 110 0.9× 84 0.8× 65 0.7× 35 1.2k
Peter P. Sayeski United States 27 980 2.4× 575 1.7× 114 1.0× 285 2.7× 46 0.5× 76 1.8k
Vincent Vuaroqueaux France 16 472 1.1× 268 0.8× 108 0.9× 122 1.2× 83 0.8× 36 868
Joaquim Calbó Spain 17 540 1.3× 463 1.4× 50 0.4× 72 0.7× 87 0.9× 23 1.1k
John Yates United Kingdom 9 918 2.2× 363 1.1× 111 1.0× 45 0.4× 32 0.3× 10 1.5k

Countries citing papers authored by Christopher J. Strock

Since Specialization
Citations

This map shows the geographic impact of Christopher J. Strock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Strock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Strock more than expected).

Fields of papers citing papers by Christopher J. Strock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Strock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Strock. The network helps show where Christopher J. Strock may publish in the future.

Co-authorship network of co-authors of Christopher J. Strock

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Strock. A scholar is included among the top collaborators of Christopher J. Strock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Strock. Christopher J. Strock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hua, Yun, et al.. (2019). Assays to Interrogate the Ability of Compounds to Inhibit the AF-2 or AF-1 Transactivation Domains of the Androgen Receptor. Assay and Drug Development Technologies. 17(8). 364–386. 7 indexed citations
3.
4.
Bradley, Jenifer A. & Christopher J. Strock. (2018). Screening for Neurotoxicity with Microelectrode Array. Current Protocols in Toxicology. 79(1). e67–e67. 22 indexed citations
5.
Hua, Yun, Daniel P. Camarco, Christopher J. Strock, & Paul A. Johnston. (2017). High Content Positional Biosensor Assay to Screen for Compounds that Prevent or Disrupt Androgen Receptor and Transcription Intermediary Factor 2 Protein-Protein Interactions. Methods in molecular biology. 1683. 211–227. 7 indexed citations
6.
Hua, Yun, et al.. (2016). Reconfiguring the AR-TIF2 Protein–Protein Interaction HCS Assay in Prostate Cancer Cells and Characterizing the Hits from a LOPAC Screen. Assay and Drug Development Technologies. 14(8). 453–477. 10 indexed citations
7.
Millard, Daniel, Christopher J. Strock, Coby B. Carlson, et al.. (2016). Identification of Drug–Drug InteractionsIn Vitro: A Case Study Evaluating the Effects of Sofosbuvir and Amiodarone on hiPSC-Derived Cardiomyocytes. Toxicological Sciences. 154(1). 174–182. 27 indexed citations
8.
Hua, Yun, Christopher J. Strock, & Paul A. Johnston. (2015). High Content Screening Biosensor Assay to Identify Disruptors of p53–hDM2 Protein-Protein Interactions. Methods in molecular biology. 1278. 555–565. 3 indexed citations
9.
Chaudhary, Khuram W., et al.. (2015). In vitro assessment of drug-induced seizure liability using a multi-electrode array based rat cortical neuronal assay. Journal of Pharmacological and Toxicological Methods. 75. 159–160. 1 indexed citations
10.
Hua, Yun, Tong Ying Shun, Christopher J. Strock, & Paul A. Johnston. (2014). High-Content Positional Biosensor Screening Assay for Compounds to Prevent or Disrupt Androgen Receptor and Transcriptional Intermediary Factor 2 Protein–Protein Interactions. Assay and Drug Development Technologies. 12(7). 395–418. 17 indexed citations
11.
Nadanaciva, Sashi, Michael D. Aleo, Christopher J. Strock, et al.. (2013). Toxicity assessments of nonsteroidal anti-inflammatory drugs in isolated mitochondria, rat hepatocytes, and zebrafish show good concordance across chemical classes. Toxicology and Applied Pharmacology. 272(2). 272–280. 38 indexed citations
12.
Feldmann, Georg, Anjali Mishra, Seung‐Mo Hong, et al.. (2010). Inhibiting the Cyclin-Dependent Kinase CDK5 Blocks Pancreatic Cancer Formation and Progression through the Suppression of Ras-Ral Signaling. Cancer Research. 70(11). 4460–4469. 138 indexed citations
13.
Shinde, Sunita, Yun Hua, Tong Ying Shun, et al.. (2010). Implementation of a 220,000-Compound HCS Campaign to Identify Disruptors of the Interaction between p53 and hDM2 and Characterization of the Confirmed Hits. SLAS DISCOVERY. 15(7). 766–782. 27 indexed citations
14.
Shinde, Sunita N., Tong Ying Shun, John S. Lazo, et al.. (2010). Characterization and Optimization of a Novel Protein–Protein Interaction Biosensor High-Content Screening Assay to Identify Disruptors of the Interactions Between p53 and hDM2. Assay and Drug Development Technologies. 8(4). 437–458. 23 indexed citations
15.
Strock, Christopher J., Jong‐In Park, Eric K. Nakakura, et al.. (2006). Cyclin-Dependent Kinase 5 Activity Controls Cell Motility and Metastatic Potential of Prostate Cancer Cells. Cancer Research. 66(15). 7509–7515. 128 indexed citations
16.
Park, Jong‐In, Christopher J. Strock, Douglas W. Ball, & Barry D. Nelkin. (2004). Interleukin-1β can mediate growth arrest and differentiation via the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells. Cytokine. 29(3). 125–134. 29 indexed citations
17.
Strock, Christopher J., Jong‐In Park, Mark Rosen, et al.. (2003). CEP-701 and CEP-751 inhibit constitutively activated RET tyrosine kinase activity and block medullary thyroid carcinoma cell growth.. PubMed. 63(17). 5559–63. 83 indexed citations
18.
Park, Jong‐In, Christopher J. Strock, Douglas W. Ball, & Barry D. Nelkin. (2003). The Ras/Raf/MEK/Extracellular Signal-Regulated Kinase Pathway Induces Autocrine-Paracrine Growth Inhibition via the Leukemia Inhibitory Factor/JAK/STAT Pathway. Molecular and Cellular Biology. 23(2). 543–554. 112 indexed citations
19.
Finkelstein, Bruce L. & Christopher J. Strock. (1997). Synthesis and Insecticidal Activity of Novel Pyrazole Methanesulfonates. Pesticide Science. 50(4). 324–328. 6 indexed citations
20.
Finkelstein, Bruce L. & Christopher J. Strock. (1997). Synthesis and Insecticidal Activity of Novel Pyrazole Methanesulfonates. Pesticide Science. 50(4). 324–328. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshiki Fukasawa Breakdown of academic impact, for papers by Antonio Chiloeches Breakdown of academic impact, for papers by Haining Zhen Breakdown of academic impact, for papers by Hadas Reuveni Breakdown of academic impact, for papers by Judit Dobos Breakdown of academic impact, for papers by Terence F. McGuire Breakdown of academic impact, for papers by Peter P. Sayeski Breakdown of academic impact, for papers by Vincent Vuaroqueaux Breakdown of academic impact, for papers by Joaquim Calbó Breakdown of academic impact, for papers by John Yates
Rankless by CCL
2026